Cardiovascular magnetic resonance imaging has emerged as the gold standard imaging modality for the characterization, prognostication, and management of hypertrophic cardiomyopathy.
What is the role and current application of cardiovascular magnetic resonance imaging in evaluating hypertrophic cardiomyopathy?
This review highlights CMR as the gold standard for evaluating hypertrophic cardiomyopathy, emphasizing its superior image quality and prognostic value over other modalities.
Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disorder, affecting 1 out of 500 adults globally. It is a widely heterogeneous disorder characterized by a range of phenotypic expressions, and is most often identified by non-invasive imaging that includes echocardiography and cardiovascular magnetic resonance imaging (CMR). Within the last two decades, cardiac magnetic resonance imaging (MRI) has emerged as the defining tool for the characterization and prognostication of cardiomyopathies. With a higher image quality, spatial resolution, and the identification of morphological variants of HCM, CMR has become the gold standard imaging modality in the assessment of HCM. Moreover, it has been crucial in its management, as well as adding prognostic information that clinical history nor other imaging modalities may not provide. This literature review addresses the role and current applications of CMR, its capacity in evaluating HCM, and its limitations.
Sanjay Sivalokanathan (Wed,) conducted a review in Hypertrophic cardiomyopathy. Cardiovascular Magnetic Resonance Imaging was evaluated. Cardiovascular magnetic resonance imaging has emerged as the gold standard imaging modality for the characterization, prognostication, and management of hypertrophic cardiomyopathy.